Heart failure and coronary artery disease in lung disease

S. Andreas (Immenhausen, Germany)

Source: International Congress 2018 – PG19 Heart-lung interaction
Session: PG19 Heart-lung interaction
Session type: Postgraduate Course
Number: 210

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Andreas (Immenhausen, Germany). Heart failure and coronary artery disease in lung disease. International Congress 2018 – PG19 Heart-lung interaction

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006

Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020




Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006

Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014


OSA and coronary artery disease
Source: Sleep and Breathing Conference 2021
Year: 2021

Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013


Assessment of pulmonary function stratifies global coronary heart disease risk
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Evaluation of pulmonary functions in valvular heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

Underestimation of bronchial obstruction in patients with coronary heart disease and cardiac insufficiency
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease
Source: Eur Respir J, 52 (3) 1800458; 10.1183/13993003.00458-2018
Year: 2018



Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019



Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Cardiovascular diseases: congenital, cardiogenic pulmonary oedema, mitral stenosis, chronic heart failure and myocardial infarction
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=290
Year: 2005

Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015